Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus.
Maneuf YP, Mitchell IJ, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Exp Neurol. 1994 Jan;125(1):65-71. doi: 10.1006/exnr.1994.1007. Exp Neurol. 1994. PMID: 8307125
Chemical signalling in the globus pallidus in parkinsonism.
Brotchie J, Crossman A, Mitchell I, Duty S, Carroll C, Cooper A, Henry B, Hughes N, Maneuf Y. Brotchie J, et al. Prog Brain Res. 1993;99:125-39. doi: 10.1016/s0079-6123(08)61342-4. Prog Brain Res. 1993. PMID: 7906423 Review. No abstract available.
Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.
Maneuf YP, Duty S, Hille CJ, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Exp Neurol. 1996 May;139(1):12-6. doi: 10.1006/exnr.1996.0075. Exp Neurol. 1996. PMID: 8635558
Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
Maneuf YP, Nash JE, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Eur J Pharmacol. 1996 Jul 18;308(2):161-4. doi: 10.1016/0014-2999(96)00326-3. Eur J Pharmacol. 1996. PMID: 8840127
The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR. Robertson RG, et al. Among authors: crossman ar. Brain Res. 1990 Oct 29;531(1-2):95-104. doi: 10.1016/0006-8993(90)90762-z. Brain Res. 1990. PMID: 2289139
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Fox SH, et al. Mov Disord. 2002 Nov;17(6):1180-7. doi: 10.1002/mds.10289. Mov Disord. 2002. PMID: 12465055
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.
Fox S, Silverdale M, Kellett M, Davies R, Steiger M, Fletcher N, Crossman A, Brotchie J. Fox S, et al. Mov Disord. 2004 May;19(5):554-60. doi: 10.1002/mds.10693. Mov Disord. 2004. PMID: 15133820 Clinical Trial.
Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats.
Ismayilova N, Crossman A, Verkhratsky A, Brotchie J. Ismayilova N, et al. Eur J Pharmacol. 2004 Aug 23;497(2):187-95. doi: 10.1016/j.ejphar.2004.06.030. Eur J Pharmacol. 2004. PMID: 15306204
Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
Bourdenx M, Nilsson A, Wadensten H, Fälth M, Li Q, Crossman AR, Andrén PE, Bezard E. Bourdenx M, et al. Among authors: crossman ar. Neurobiol Dis. 2014 Feb;62:307-12. doi: 10.1016/j.nbd.2013.10.016. Epub 2013 Oct 19. Neurobiol Dis. 2014. PMID: 24148855
Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
Kobylecki C, Crossman AR, Ravenscroft P. Kobylecki C, et al. Among authors: crossman ar. Exp Neurol. 2013 Sep;247:476-84. doi: 10.1016/j.expneurol.2013.01.019. Epub 2013 Jan 27. Exp Neurol. 2013. PMID: 23360800
156 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page